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validez, sensibilidad y especificidad2,11. Habiendo cumplido
con las expectativas del primer an˜o de monitoreo, además
de la implementación de programas de mejora, lo que sigue
es ampliar el número de indicadores y ajustar los estándares
con la nueva evidencia disponible. La expansión del monito-
reo de calidad solo puede redundar en beneficios sin requerir
grandes inversiones ni tecnología compleja.
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H1N1 influenza virus-associated
encephalitis: A case report
Encefalitis asociada al virus de la gripe H1N1:
un caso clínico
Febrile respiratory symptoms represent the most common
clinical manifestations of infection with 2009 H1N1 virus
and are in general mild and self-limited. Since the 2009
H1N1 pandemic several neurologic complications have been
described. Children and young adults are preferentially
affected. We report a case of H1N1-associated encephalitis
in an adult patient.
A 56-year-old male nurse, with a past medical history sig-
nificant for hypertension and right-sided nephrectomy for
congenital hydronephrosis, was admitted, initially to the
emergency department of another hospital, with a 5-day
history of influenza-like illness including lethargy, high fever
and nonproductive cough. A nasopharyngeal swab was per-
formed to test for the H1N1 virus.
On admission the patient was febrile, but otherwise his
other vital signs were stable. He was conscious and orien-
ted. The rest of the physical and neurologic examination was
unremarkable.
Laboratory studies revealed normal white blood cell
count, thrombocytopenia of 77× 109/L and elevated C-
reactive protein of 15.8mg/dL. Serum electrolytes and renal
and liver function tests were within normal limits. Chest
radiograph demonstrated consolidation of the left lower
lobe. He was diagnosed with community-acquired pneu-
monia and broad-spectrum antibiotic therapy consisted of
intravenous ceftriaxon and azitrothromycin was initiated.
On day 2 of hospitalization antiviral therapy with Oseltami-
vir 150mg/day was associated after nasopharyngeal swab
confirmed H1N1 virus infection.
Despite antibiotic and antiviral therapies, his respiratory
status worsened. On day 3 he developed acute respiratory
distress syndrome requiring intubation and he was trans-
ferred to the intensive care unit.
Therapy with Oseltamivir was discontinued after 9 days.
Throughout his ICU-stay he remained febrile. After success-
ful weaning from mechanical ventilation and sedation the
patient was extubated on ICU-day 10. During the following
day’s he was noted to have fever, fluctuating mental status
and disorientation.
A computed tomography scan of the brain showed bila-
teral cortical and subcortical vasogenic cerebral edema
with areas of hemorrhage, involving the right fronto-
parietal lobe, the left occipital lobe and the left cerebellar
hemisphere, with mass effect on the left ventricle
with midline shift and subfalcial and right-sided uncal
herniation.
The patient was put on antiedemic therapy and trans-
ferred to our institution for observation by neurosurgery.
Just before being transported he required reintubation for
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Figure 1 The right-hemispheric lesion area. Brain magnetic resonance images showed extensive vasogenic edema with hemorr-
hagic foci in the right cerebral hemisphere predominantly in the right perirolandic and fronto-temporal regions with hyperintense
signal. Following intravenous gadolinium administration leptomeningeal contrast enhancement in the right temporal lobe was
observed.
Table 1 Clinicopathologic features of previously reported cases of H1N1 influenza-associated encephalopathy/encephalitis in
adults.
Author Sex Age (years) Interval ILI-neurologic
symptoms (days)
Neurologic symptoms CSF
Fugate et al.2 Male 40 30 Acute drop on the
bispectral index monitor
No pleocytosis
Elevated protein level
RT-PCR H1N1-ND
Akins et al.3 Male 20 6 Confusion, seizures Pleocytosis
Elevated protein level
RT-PCR H1N1 negative
Chen et al.4 Male 40 2 Tremors, clumsiness,
right hemiplegia
Pleocytosis
Elevated protein level
RT-PCR H1N1-ND
Ito et al.5 Male 26 Unknown Memory disturbance,
disorientation,
drowsiness
Mild pleocytosis
Normal protein level
RT-PCR H1N1 negative
Gonzalez et al.6 Female 46 3 Confusion No pleocytosis
Normal protein level
RT-PCR H1N1 negative
Tsai et al.7 Male 46 4 Acute delirium No pleocytosis
Normal protein level
RT-PCR H1N1 negative
Author MRI EEG Antiviral therapy Prognosis
Fugate et al.2 Subcortical lesions with
hemorrhages and edema
Normal Oseltamivir Severe sequelae
Akins et al.3 White matter lesions,
diffuse edema
Bilateral diffuse
continuous slow  waves
Oseltamivir 150mg/dia Mild sequelae
Chen et al.4 Cortical and subcortical
areas of the
frontal-parietal lobe
Diffuse slowing of
cortical activity
Oseltamivir Severe sequelae
Ito et al.5 Corpus callosum Normal Oseltamivir 150mg/day Complete recovery
Gonzalez et al.6 Normal ND Oseltamivir Complete recovery
Tsai et al.7 White matter lesions Bilateral diffuse
continuous slow  waves
Oseltamivir 150mg/day Deceased
ND: not done; ILI: influenza-like illness; CSF: cerebrospinal fluid; EEG: electroencephalography.
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airway protection because of a rapid deterioration of his
consciousness level. On admission to our hospital, he was
found to have right gaze deviation and left-sided hemiple-
gia. There was no indication for neurosurgical treatment
and the patient was admitted to our ICU on suspicion of
H1N1-associated encephalitis.
A lumbar puncture was performed. The CSF contained
white blood cell count of <1.0/L, no red blood cells, a
normal glucose level and an increased protein level. Furt-
her work-up to exclude other possible causes of encephalitis
included: (1) CSF polymerase chain reaction (PCR) for neu-
rotropic virus was negative, including RT-PCR for 2009 H1N1
virus; (2) Cultures of blood, urine, tracheobronchial aspirate
and CSF were negative; (3) Serology for mycoplasma pneu-
monia, Chlamydia, Rickettsia, hepatitis B and C, syphilis
and HIV antibody was negative; (4) Testing for autoimmune
disorders was within normal limits.
Brain magnetic resonance images (MRI) revealed exten-
sive vasogenic edema with hemorrhagic foci in the right
cerebral hemisphere with hyperintense signal lesions (T2
FLAIR) in left occipital lobe, left cerebellar hemisphere and
bulbus. Following intravenous gadolinium administration
leptomeningeal contrast enhancement in the right temporal
lobe was observed (fig. 1).
After discontinuation of sedation his level of conscious-
ness gradually improved over the following days. Further
intensive care course was uneventful and the patient was
extubated on day 9. He was discharged on ICU-day 12, cons-
cious, but still with periods of disorientation, and left sided
hemiplegia. Almost complete recovery of his hemiplegia was
noted one month after ICU discharge.
To the best of our knowledge, this is the first reported
case of H1N1-associated encephalitis in an adult patient in
Portugal. Although we were not able to identify the H1N1
virus by RT-PCR in the CSF as the causative agent, the combi-
nation of clinical and radiological findings and the exclusion
of other competing diagnosis are, in our opinion, most con-
sistent with this diagnosis.
H1N1-associated encephalitis was defined by the Cen-
ter of Disease Control and Prevention as altered mental
status >24 h, in patients with laboratory-confirmed H1N1
virus infection, within 5 days of influenza-like illness symp-
tom onset plus two or more of the following: fever, focal
neurological signs, CSF pleocytosis, EEG and/or abnormal
neuroimaging indicative of encephalitis.1 Our patient almost
fulfilled all of these criteria. However it is noteworthy that
neurological signs and symptoms were noted almost 20 days
after the initial onset of respiratory illness when sedation
was discontinued.
From a review of the English literature, we found one
case of acute hemorrhagic leukoencephalitis2 and five adult
cases of H1N1-associated encephalitis/encephalopathy3--7
(table 1).
All patients were previously healthy, aged between 20
and 46 years, five were male and one was female. The
most frequent initial clinical manifestations were influenza-
like symptoms. Neurological symptoms included drowsiness,
memory disturbance, disorientation, confusion, tremors and
focal signs starting between 1 and 6 days after onset of
illness. All patients had a laboratory-confirmed (nasop-
haryngeal swab) H1N1 virus infection. However, like in our
patient, H1N1 RNA was not detected in CSF by RT-PCR. Other
findings of CSF included elevated leukocyte counts and/ or
elevated protein levels. Neuroimaging findings were varia-
ble ranging from normal to cortical and subcortical lesions,
like in our patient, to involvement of deep brain structures
with or without brain edema. All patients were treated with
Oseltamivir. Two patients received simultaneously treat-
ment with corticosteroids. There was a complete recovery
of neurologic manifestations in two patients; in three other
patients mild to severe neurologic sequelae were noted.
In conclusion, encephalitis is a rare neurological compli-
cation of influenza H1N1 virus in adults. By publishing this
case report we hope to contribute by the further cha-
racterization of this group of patients. H1N1-associated
encephalitis must be considered in the differential diagno-
sis in patients with influenza-like illness and altered mental
status. Diagnosis is based on neurological and neuroimaging
findings, and CSF analysis in combination with laboratory-
confirmed H1N1 respiratory tract infection.
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